Results 91 to 100 of about 27,184 (256)

Rapid Initiation of Antiretroviral Therapy with Coformulated Bictegravir, Emtricitabine, Tenofovir Alafenamide Versus Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate in HIV-positive Men Who Have Sex with Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial.

Clinical Infectious Diseases
BACKGROUND Most international treatment guidelines recommend rapid initiation of antiretroviral therapy (ART) for people newly diagnosed with HIV-1 infection, but experiences with rapid ART initiation remain limited in China.
Ran Wang, Lijun Sun, Xi Wang, Yuanyi Zhai, Lijing Wang, Ping Ma, Cuisong Wu, Yingquan Zhou, Renfang Chen, Rugang Wang, Fengchi Zhang, Wei Hua, Aixin Li, Wei Xia, Yue Gao, Rui Li, Shiyun Lv, Y. Shao, Yu Cao, Tong Zhang, Hao Wu, Chao Cai, Lili Dai   +22 more
semanticscholar   +1 more source

Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 2, Page 254-263, January 2026.
Hepatitis B immunoglobulins withdrawal in hepatitis B virus mono‐infected liver transplant recipients: An Italian multicentre prospective study. ABSTRACT Background & Aims Despite recommendations from scientific societies that hepatitis B immunoglobulin (HBIG) can be safely discontinued, centres across Europe continue to use the combination nucleoside ...
Raffaella Viganò, Alessandro Loglio, Clara Dibenedetto, Paola Carrai, Silvia Martini, Ilaria Lenci, Bianca Magro, Sara Conti, Paolo Angelo Cortesi, Chiara Mazzarelli, Chiara Becchetti, Giovanni Perricone, Monica Cucco, Marco Carbone, Donatella Cocchis, Elisa Farina, Luisa Pasulo, Mauro Viganò, Michele Sagasta, Elisabetta Degasperi, Davide Ghinolfi, Pietro Lampertico, Stefano Fagiuoli, Luca Saverio Belli, on behalf of the INSIGHT‐B study group   +24 more
wiley   +1 more source

2016 Pipeline Report HIV and TB [PDF]

, 2016
HIV and TB: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in ...
Erica Lessem, Lindsay McKenna, Mark Harrington, Mike Frick, Polly Clayden, Richard Jefferys, Simon Collins, Tim Horn   +7 more
core  

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe [PDF]

, 2018
Background: HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains.
Alvarez, M.R. (Marta), Ben Ari, Z. (Ziv), Boland, G.J. (Greet), Boucher, C.A.B. (Charles), Bruzzone, B. (Bianca), Colagrossi, L. (Luna), Coppola, N. (Nicola), Di Carlo, D., Dyda, T. (Tomasz), Garcia, F. (Federico), Hermans, L.E. (Lucas Etienne), Kaiser, R. (Rolf), Krarup, H.B. (H.), Köse, S. (Sukran), Lazarevic, I. (Ivana), Lepej, S.Z. (Snjezana), Lunar, M.M. (Maja M.), Maylin, S. (Sarah), Micheli, V. (Valeria), Mor, O. (Orna), Paraschiv, C. (Corina), Paraskevis, D. (Dimitrios), Pas, S.D. (Suzan), Perno, C.F. (Carlo), Poljak, M. (Mario), Puchhammer-Stöckl, E. (Elisabeth), Salpini, R. (Romina), Seguin-Devaux, C., Simon, F. (François), Stanojevic, M. (Maja), Stene-Johansen, K. (Kathrine), Svicher, V. (Valentina), Tihic, N. (Nijaz), Trimoulet, P. (Pascale), Verheyen, J. (Jens), Vince, A. (Adriana), Weis, N. (Nina), Wensing, A. (Amj), Yalcinkaya, T. (Tülay)   +38 more
core   +2 more sources

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton   +4 more
wiley   +1 more source

Intersections of vitamin D deficiency, HIV and chronic liver diseases

HIV Medicine, Volume 27, Issue 1, Page 4-17, January 2026.
Abstract Objectives Despite effective antiretroviral therapy (ART), chronic liver diseases remain a leading cause of morbidity and mortality among people with HIV, with metabolic dysfunction–associated steatotic liver disease (MASLD) now the predominant etiology. Vitamin D deficiency is also highly prevalent in this population.
Francesca Farina, Aurgho Datta, Suzanne N. Morin, Sahar Saeed, Bertrand Lebouche, Giovanni Guaraldi, Salvatore Petta, Giada Sebastiani   +7 more
wiley   +1 more source

Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service

AIDS Research and Therapy, 2019
Background Tenofovir disoproxil fumarate (TDF) is widely used in the management of HIV-infection, but has been associated with renal impairment in a small proportion of patients.
Dane Turner, Douglas Drak, Catherine C. O’Connor, David J. Templeton, David M. Gracey   +4 more
doaj   +1 more source

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure. [PDF]

, 2019
Hepatitis B virus (HBV) is one of the most significant hepatocarcinogens. The ultimate goal of anti-HBV treatment is to prevent the development of hepatocellular carcinoma (HCC).
Coben, Robert M., Conn, Mitchell I., DiMarino, Anthony J., Hann, Hie-Won, Kroop, Howard, Martin, Aaron, Prieto, Jorge, Shinn, Brianna J.   +7 more
core   +1 more source

Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study

Aids and Behavior
SOLAR (NCT04542070; registered 2020–09-09) is a Phase 3b study that demonstrated the noninferior virological efficacy of switching to cabotegravir + rilpivirine long-acting (CAB + RPV LA) dosed every 2 months vs.
C. Mussini, C. Cazanave, E. Adachi, B. Eu, Marta Montero Alonso, G. Crofoot, Vasiliki Chounta, Irina Kolobova, K. Sutton, Denise Sutherland-Phillips, R. Urbaityte, Alice Ehmann, Jenny Scherzer, Patricia de los Rios, Ronald D'Amico, W. Spreen, J. van Wyk   +16 more
semanticscholar   +1 more source

Tenofovir alafenamide [PDF]

Reactions Weekly, 2020
  +4 more sources